Premium
Photocontrolled Release of the Anticancer Drug Chlorambucil with Caged Harmonic Nanoparticles
Author(s) -
Vuilleumier Jérémy,
Gaulier Geoffrey,
De Matos Raphaël,
Mugnier Yannick,
Campargue Gabriel,
Wolf JeanPierre,
Bonacina Luigi,
GerberLemaire Sandrine
Publication year - 2020
Publication title -
helvetica chimica acta
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.74
H-Index - 82
eISSN - 1522-2675
pISSN - 0018-019X
DOI - 10.1002/hlca.201900251
Subject(s) - chlorambucil , doxorubicin , nanoparticle , drug , drug delivery , materials science , moiety , pharmacology , chemistry , nanotechnology , chemotherapy , stereochemistry , cyclophosphamide , medicine , surgery
While chemotherapy is one of the most used treatments in oncology, the systemic administration of chemotherapeutics generally results in undesired damages to healthy tissues and cells, side effects such as severe nausea and leukopenia, and reduced efficacy due to multidrug resistance and poor target accessibility. The limitations of conventional chemotherapy formulation have prompted the development of alternative nanomaterials‐based strategies to achieve targeted and stimuli sensitive payload delivery to reach optimal local drug concentration at tumor sites. In this study, the anticancer drug chlorambucil (Clb) was conjugated to the surface of silica coated lithium niobate (LNO) harmonic nanoparticles (HNPs) using a photocaging tether based on coumarin‐4‐yl methyl derivative. Upon laser pulsed femtosecond irradiation at 790 nm, the second harmonic emission from the metal oxide core induced the efficient release of Clb, with concomitant contribution from the nonlinear absorption of the coumarin (CM)‐based moiety.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom